Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | AGXT | P21549 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16267795 | 0.82 | MAOA (0.44) | LOXL2CYP2A6HTR2ASMN1; SMN2TAAR1 | |
| SCHEMBL8983632 | 0.79 | TDP1 (0.44) | TSHRCALM1IDO1ALDH1A1LOXL2 | |
| SCHEMBL12971195 | 0.79 | TSHR (0.40) | TSHRCALM1IDO1ALDH1A1LOXL2 | |
| SCHEMBL3341648 | 0.79 | TP53 (0.42) | TSHRCALM1IDO1ALDH1A1LOXL2 | |
| SCHEMBL19816465 | 0.77 | TSHR (0.39) | TSHRCALM1IDO1ALDH1A1LOXL2 | |
| SCHEMBL7116446 | 0.77 | TSHR (0.39) | TSHRCALM1IDO1ALDH1A1LOXL2 | |
| SCHEMBL7116444 | 0.77 | TSHR (0.39) | TSHRCALM1IDO1ALDH1A1LOXL2 | |
| SCHEMBL3338279 | 0.75 | TP53 (0.44) | TSHRCALM1IDO1ALDH1A1LOXL2 | |
| SCHEMBL19514749 | 0.74 | AGXT (0.44) | IDO1ALDH1A1TP53AGXTTDP1 | |
| SCHEMBL5388447 | 0.74 | TSHR (0.42) | TSHRCALM1IDO1ALDH1A1LOXL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 403 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111655791-B | Pest and ice phobic compositions with fluid additives | HRL实验室有限责任公司 | 2022-11-04 | — | — | CN | claimed |
| US-11072713-B2 | Bugphobic and icephobic compositions with fluid additives | HRL LABORATORIES, LLC (US) | 2021-07-27 | — | — | US | claimed |
| EP-3746509-A1 | BUGPHOBIC AND ICEPHOBIC COMPOSITIONS WITH FLUID ADDITIVES | HRL Laboratories, LLC (US) | 2020-12-09 | — | — | EP | claimed |
| CN-111655791-A | Pest and ice phobic compositions with fluid additives | HRL实验室有限责任公司 | 2020-09-11 | — | — | CN | claimed |
| WO-2019152081-A1 | BUGPHOBIC AND ICEPHOBIC COMPOSITIONS WITH FLUID ADDITIVES | HRL LABORATORIES, LLC (US) | 2019-08-08 | — | — | WO | claimed |
| US-20190023910-A1 | BUGPHOBIC AND ICEPHOBIC COMPOSITIONS WITH FLUID ADDITIVES | HRL LABORATORIES, LLC | 2019-01-24 | — | — | US | claimed |
| EP-2776382-B1 | 18F-SACCHARIDE-FOLATES | Merck & Cie (CH) | 2018-09-19 | — | — | EP | claimed |
| CN-104530417-B | A kind of multiple functionalized H types polyethyleneglycol derivative and preparation method thereof | 厦门赛诺邦格生物科技股份有限公司 | 2017-09-08 | — | — | CN | claimed |
| CN-104530415-B | A kind of different functionalization Y types polyethyleneglycol derivative, preparation method and its bio-related substance | 厦门赛诺邦格生物科技股份有限公司 | 2017-09-01 | — | — | CN | claimed |
| EP-2308861-B1 | MACROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICALS | EISAI R&D MAN CO LTD (JP) | 2017-03-01 | — | — | EP | claimed |
| US-8334099-B2 | Nucleic acid amplification using a reversibly modified oligonucleotide | BI WANLI (US) | 2012-12-18 | — | — | US | claimed |
| EP-2049689-B1 | NUCLEIC ACID AMPLIFICATION USING A REVERSIBLY MODIFIED OLIGONUCLEOTIDE | BI WANLI (US) | 2011-12-21 | — | — | EP | claimed |
| US-20100021970-A1 | Nucleic Acid Amplification Using a Reversibly Modified Oligonucleotide | BI WANLI | 2010-01-28 | — | — | US | claimed |
| EP-2049689-A2 | NUCLEIC ACID AMPLIFICATION USING A REVERSIBLY MODIFIED OLIGONUCLEOTIDE | Bi, Wanli (US) | 2009-04-22 | — | — | EP | claimed |
| WO-2008016562-A2 | NUCLEIC ACID AMPLIFICATION USING A REVERSIBLY MODIFIED OLIGONUCLEOTIDE | BI WANLI (US) | 2008-02-07 | — | — | WO | claimed |
| WO-2008013427-A1 | ORGANIC TFTS AND METHOD FOR FABRICATING THE SAME | LG CHEM, LTD. (KR) | 2008-01-31 | — | — | WO | claimed |
| JP-2006516295-A | — | — | 2006-06-29 | — | — | JP | claimed |
| CN-1744918-A | Polymeric reagents comprising a ketone or a related functional group | NEKTAR THERAPEUTICS AL CORP (US) | 2006-03-08 | — | — | CN | claimed |
| EP-1581260-A2 | POLYMERIC REAGENTS COMPRISING A KETONE OR A RELATED FUNCTIONAL GROUP | Nektar Therapeutics Al, Corporation (US) | 2005-10-05 | — | — | EP | claimed |
| WO-2004060406-A2 | POLYMERIC REAGENTS COMPRISING A KETONE OR A RELATED FUNCTIONAL GROUP | NEKTAR THERAPEUTICS AL, CORPORATION (US) | 2004-07-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11072713-B2 | Bugphobic and icephobic compositions with fluid additives | FUS, IGF2BP1, IGF2BP3 | TSHR 3345/4885CALM1 3835/4885IDO1 1729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.